Literature DB >> 14717429

Primary malignant schwannoma of the lung.

Ken-ichi Togashi1, Hiroyuki Hirahara, Masaaki Sugawara, Fumiaki Oguma.   

Abstract

A 72-year-old male referred for surgical treatment underwent chest computed tomography to further investigate a well defined mass with a maximal diameter of 3.2 cm at the left S10. There was no pathological diagnosis established by either bronchoscopic biopsy specimens or computed tomography-guided percutaneous needle biopsy. The lower lobe and mediastinal lymph nodes were excised (complete resection). The 6.5-cm encapsulated grayish mass showed extensive areas of hemorrhage and necrosis on cut surface. Results from histological and immunohistochemical study yielded a definitive diagnosis of malignant schwannoma. Primary malignant schwannomas of the lung are extremely rare and the prognosis is poor in most cases. Our patient is currently well without recurrence more than 2 years after complete resection. Complete surgical resection is the best therapeutic option for primary malignant schwannoma of the lung.

Entities:  

Mesh:

Year:  2003        PMID: 14717429     DOI: 10.1007/s11748-003-0014-7

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  10 in total

1.  Primary lung sarcomas: long survivors obtained with iterative complete surgery.

Authors:  N Magné; B Porsin; X Pivot; X Tchiknavorian; P Y Marcy; C Foa; J Otto; M Schneider; A Thyss
Journal:  Lung Cancer       Date:  2001 Feb-Mar       Impact factor: 5.705

2.  Primary pulmonary sarcoma: a clinicopathologic study of 26 cases.

Authors:  S B Keel; E Bacha; E J Mark; G P Nielsen; A E Rosenberg
Journal:  Mod Pathol       Date:  1999-12       Impact factor: 7.842

3.  Primary sarcoma of the lung.

Authors:  N Martini; S I Hajdu; E J Beattie
Journal:  J Thorac Cardiovasc Surg       Date:  1971-01       Impact factor: 5.209

4.  Surgical treatment of primary sarcoma of the lung.

Authors:  H L Porte; D G Metois; X Leroy; M Conti; B Gosselin; A Wurtz
Journal:  Eur J Cardiothorac Surg       Date:  2000-08       Impact factor: 4.191

5.  Surgical treatment of primary pulmonary sarcomas.

Authors:  E A Bacha; C D Wright; H C Grillo; J C Wain; A Moncure; S B Keel; D M Donahue; D J Mathisen
Journal:  Eur J Cardiothorac Surg       Date:  1999-04       Impact factor: 4.191

6.  [Chronological changes of lung sarcoma and lung cancer incidence based on the annual of the pathological autopsy cases in Japan (1958-1986)].

Authors:  T Morita
Journal:  Nihon Kyobu Shikkan Gakkai Zasshi       Date:  1990-01

7.  Primary sarcomas of the lung: a clinicopathologic study of 12 cases.

Authors:  Bénédicte Etienne-Mastroianni; Lionel Falchero; Lara Chalabreysse; Robert Loire; Dominique Ranchère; Pierre Jean Souquet; Jean François Cordier
Journal:  Lung Cancer       Date:  2002-12       Impact factor: 5.705

8.  Primary pulmonary tumours of neurogenic origin.

Authors:  G Roviaro; M Montorsi; F Varoli; R Binda; A Cecchetto
Journal:  Thorax       Date:  1983-12       Impact factor: 9.139

9.  Primary sarcoma of the lung: a clinical study with long-term follow-up.

Authors:  J P Janssen; J J Mulder; S S Wagenaar; H R Elbers; J M van den Bosch
Journal:  Ann Thorac Surg       Date:  1994-10       Impact factor: 4.330

Review 10.  [A case of intrapulmonary schwannoma and a review of the Japanese literature].

Authors:  Y Uchiyama; H Minami; M Yamashita; K Aduma; T Takahashi; A Nakamura
Journal:  Nihon Kyobu Geka Gakkai Zasshi       Date:  1989-06
  10 in total
  2 in total

1.  Spinal cord metastasis of a non-neurofibromatosis type-1 malignant peripheral nerve sheath tumor: an unusual manifestation of a rare tumor.

Authors:  William S Baek; Peter Pytel; Samir D Undevia; Helene Rubeiz
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

2.  Successful Radiotherapy of Primary Malignant Peripheral Nerve Sheath Tumor of the Lung.

Authors:  Katsuya Yanagisawa; Kenichi Nishie; Hidekazu Takahashi; Kenji Sano; Kazuyoshi Takei; Hiroshi Yamamoto; Tomonobu Koizumi; Masayuki Hanaoka
Journal:  Intern Med       Date:  2022-03-15       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.